Clinical characteristics of 182 pediatric COVID‐19 patients with different severities and allergic status
Allergy2020Vol. 76(2), pp. 510–532
Citations Over TimeTop 10% of 2020 papers
Hui Du, Xiang Dong, Jinjin Zhang, Yiyuan Cao, Mübeccel Akdiş, Peiqi Huang, Hongwei Chen, Ying Li, Guang‐hui Liu, Cezmi A. Akdiş, Xiaoxia Lü, Yadong Gao
Abstract
Pediatric COVID-19 patients tended to have a mild clinical course. Patients with pneumonia had higher proportion of fever and cough and increased inflammatory biomarkers than those without pneumonia. There was no difference between allergic and nonallergic COVID-19 children in disease incidence, clinical features, and laboratory and immunological findings. Allergy was not a risk factor for developing and severity of SARS-CoV-2 infection and hardly influenced the disease course of COVID-19 in children.
Related Papers
- → Eosinopenia as Predictor of Poor Outcome in Hospitalized COVID-19 Adult Patients from Waves 1 and 2 of 2020 Pandemic(2022)14 cited
- → Search for eosinopenia in hospitalized patients with normal blood leukocyte concentration(1987)33 cited
- → 30 day mortality and eosinopenia in patients with pneumonia(2014)11 cited
- → A Study to Evaluate the Role of Eosinophil Count as a Prognostic Marker for Assessing the Outcome in Patients with COVID-19 Infection(2022)4 cited
- → Eosinopenia as a Diagnostic Marker in Covid-19?(2020)2 cited